BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23602943)

  • 1. Exposure and response prevention with or without parent management training for children with obsessive-compulsive disorder complicated by disruptive behavior: a multiple-baseline across-responses design study.
    Sukhodolsky DG; Gorman BS; Scahill L; Findley D; McGuire J
    J Anxiety Disord; 2013 Apr; 27(3):298-305. PubMed ID: 23602943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EFFECTS OF HOMEWORK COMPLIANCE ON COGNITIVE-BEHAVIORAL THERAPY WITH D-CYCLOSERINE AUGMENTATION FOR CHILDREN WITH OBSESSIVE COMPULSIVE DISORDER.
    Olatunji BO; Rosenfield D; Monzani B; Krebs G; Heyman I; Turner C; Isomura K; Mataix-Cols D
    Depress Anxiety; 2015 Dec; 32(12):935-43. PubMed ID: 26372401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difficult-to-treat pediatric obsessive-compulsive disorder: feasibility and preliminary results of a randomized pilot trial of D-cycloserine-augmented behavior therapy.
    Farrell LJ; Waters AM; Boschen MJ; Hattingh L; McConnell H; Milliner EL; Collings N; Zimmer-Gembeck M; Shelton D; Ollendick TH; Testa C; Storch EA
    Depress Anxiety; 2013 Aug; 30(8):723-31. PubMed ID: 23722990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case study: behavioral treatment of obsessive-compulsive disorder in a boy with comorbid disruptive behavior problems.
    Owens EB; Piacentini J
    J Am Acad Child Adolesc Psychiatry; 1998 Apr; 37(4):443-6. PubMed ID: 9549966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of comorbidity on cognitive-behavioral therapy response in pediatric obsessive-compulsive disorder.
    Storch EA; Merlo LJ; Larson MJ; Geffken GR; Lehmkuhl HD; Jacob ML; Murphy TK; Goodman WK
    J Am Acad Child Adolesc Psychiatry; 2008 May; 47(5):583-592. PubMed ID: 18356759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the therapy manual or the therapist matter most in treatment of obsessive-compulsive disorder? A randomized controlled trial of exposure with response or ritual prevention in 118 patients.
    van Oppen P; van Balkom AJ; Smit JH; Schuurmans J; van Dyck R; Emmelkamp PM
    J Clin Psychiatry; 2010 Sep; 71(9):1158-67. PubMed ID: 20361906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adding acceptance and commitment therapy to exposure and response prevention for obsessive-compulsive disorder: A randomized controlled trial.
    Twohig MP; Abramowitz JS; Smith BM; Fabricant LE; Jacoby RJ; Morrison KL; Bluett EJ; Reuman L; Blakey SM; Ledermann T
    Behav Res Ther; 2018 Sep; 108():1-9. PubMed ID: 29966992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the addition of cognitive therapy to exposure and response prevention for obsessive compulsive disorder enhance clinical efficacy? A randomized controlled trial in a community setting.
    Rector NA; Richter MA; Katz D; Leybman M
    Br J Clin Psychol; 2019 Mar; 58(1):1-18. PubMed ID: 29984550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining Treatment Outcomes in Pediatric Obsessive-Compulsive Disorder Using a Self-Report Scale.
    McGuire JF; Geller DA; Murphy TK; Small BJ; Unger A; Wilhelm S; Storch EA
    Behav Ther; 2019 Mar; 50(2):314-324. PubMed ID: 30824248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metacognitive therapy versus exposure and response prevention for obsessive-compulsive disorder: study protocol for a randomized controlled trial.
    Melchior K; Franken I; Deen M; van der Heiden C
    Trials; 2019 May; 20(1):277. PubMed ID: 31109349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediators of exposure therapy for youth obsessive-compulsive disorder: specificity and temporal sequence of client and treatment factors.
    Chu BC; Colognori DB; Yang G; Xie MG; Lindsey Bergman R; Piacentini J
    Behav Ther; 2015 May; 46(3):395-408. PubMed ID: 25892174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep-Related Problems in Pediatric Obsessive-Compulsive Disorder and Intensive Exposure Therapy.
    Nabinger de Diaz NA; Farrell LJ; Waters AM; Donovan C; McConnell HW
    Behav Ther; 2019 May; 50(3):608-620. PubMed ID: 31030877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure and response prevention versus stress management training for adults and adolescents with obsessive compulsive disorder: A randomized clinical trial.
    Himle JA; Grogan-Kaylor A; Hiller MA; Mannella KA; Norman LJ; Abelson JL; Prout A; Shunnarah AA; Becker HC; Russman Block SR; Taylor SF; Fitzgerald KD
    Behav Res Ther; 2024 Jan; 172():104458. PubMed ID: 38103359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.
    Foa EB; Liebowitz MR; Kozak MJ; Davies S; Campeas R; Franklin ME; Huppert JD; Kjernisted K; Rowan V; Schmidt AB; Simpson HB; Tu X
    Am J Psychiatry; 2005 Jan; 162(1):151-61. PubMed ID: 15625214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metacognitive therapy versus exposure and response prevention for obsessive-compulsive disorder - A non-inferiority randomized controlled trial.
    Exner C; Kleiman A; Haberkamp A; Hansmeier J; Milde C; Glombiewski JA
    J Anxiety Disord; 2024 Jun; 104():102873. PubMed ID: 38729024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-cycloserine augmentation in behavioral therapy for obsessive-compulsive disorder: a meta-analysis.
    Xia J; Du Y; Han J; Liu G; Wang X
    Drug Des Devel Ther; 2015; 9():2101-17. PubMed ID: 25960632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Randomized Controlled Trial of OC-Go for Childhood Obsessive-Compulsive Disorder: Augmenting Homework Compliance in Exposure With Response Prevention Treatment.
    Tuerk PW; McGuire JF; Piacentini J
    Behav Ther; 2024 Mar; 55(2):306-319. PubMed ID: 38418042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does Exposure and Response Prevention Behaviorally Activate Patients With Obsessive-Compulsive Disorder? A Preliminary Test.
    Blakey SM; Abramowitz JS; Leonard RC; Riemann BC
    Behav Ther; 2019 Jan; 50(1):214-224. PubMed ID: 30661561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Augmentation of Cognitive Behavior Therapy With Weight-Adjusted d-Cycloserine vs Placebo in Pediatric Obsessive-Compulsive Disorder: A Randomized Clinical Trial.
    Storch EA; Wilhelm S; Sprich S; Henin A; Micco J; Small BJ; McGuire J; Mutch PJ; Lewin AB; Murphy TK; Geller DA
    JAMA Psychiatry; 2016 Aug; 73(8):779-88. PubMed ID: 27367832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining treatment response and remission in obsessive-compulsive disorder: a signal detection analysis of the Children's Yale-Brown Obsessive Compulsive Scale.
    Storch EA; Lewin AB; De Nadai AS; Murphy TK
    J Am Acad Child Adolesc Psychiatry; 2010 Jul; 49(7):708-17. PubMed ID: 20610140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.